Enhancement of oxaliplatin efficacy and amelioration of intestinal epithelial damage by Lactobacillus rhamnosus GG through modulation of gut microbiota

Enhancement of oxaliplatin efficacy and amelioration of intestinal epithelial damage by Lactobacillus rhamnosus GG through modulation of gut microbiota

BackgroundNon-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide, necessitating extensive research into effective treatment strategies. Despite advancements in targeted therapies and immunotherapies, traditional chemotherapy remains the primary treatment modality...

Full description

Saved in:
Bibliographic Details
Main Authors: Zijie Zhang, Rui Li, Yilin Ren, Yalan Ni, Xiaoyu Shen, Deli Yi, Zheng-hong Xu, Yan Geng, Qingjun You
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Microbiology
Subjects:
non-small cell lung cancer
chemotherapy
probiotics
gut microbiota
oncology therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1565880/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items